nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—Epigastric discomfort—Hydrochlorothiazide—nephrolithiasis	0.071	0.071	CcSEcCtD
Tinidazole—Numbness—Hydrochlorothiazide—nephrolithiasis	0.045	0.045	CcSEcCtD
Tinidazole—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0431	0.0431	CcSEcCtD
Tinidazole—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0352	0.0352	CcSEcCtD
Tinidazole—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0285	0.0285	CcSEcCtD
Tinidazole—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0279	0.0279	CcSEcCtD
Tinidazole—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0255	0.0255	CcSEcCtD
Tinidazole—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0244	0.0244	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0244	0.0244	CcSEcCtD
Tinidazole—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0219	0.0219	CcSEcCtD
Tinidazole—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0219	0.0219	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0207	0.0207	CcSEcCtD
Tinidazole—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0205	0.0205	CcSEcCtD
Tinidazole—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0203	0.0203	CcSEcCtD
Tinidazole—Sweating—Hydrochlorothiazide—nephrolithiasis	0.02	0.02	CcSEcCtD
Tinidazole—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0186	0.0186	CcSEcCtD
Tinidazole—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0186	0.0186	CcSEcCtD
Tinidazole—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0177	CcSEcCtD
Tinidazole—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0174	0.0174	CcSEcCtD
Tinidazole—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0161	0.0161	CcSEcCtD
Tinidazole—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.016	0.016	CcSEcCtD
Tinidazole—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0157	0.0157	CcSEcCtD
Tinidazole—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0151	CcSEcCtD
Tinidazole—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0149	CcSEcCtD
Tinidazole—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0147	CcSEcCtD
Tinidazole—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0147	CcSEcCtD
Tinidazole—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0146	0.0146	CcSEcCtD
Tinidazole—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0144	CcSEcCtD
Tinidazole—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0139	CcSEcCtD
Tinidazole—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0139	CcSEcCtD
Tinidazole—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0137	CcSEcCtD
Tinidazole—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0134	CcSEcCtD
Tinidazole—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.013	0.013	CcSEcCtD
Tinidazole—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0129	CcSEcCtD
Tinidazole—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0127	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0121	CcSEcCtD
Tinidazole—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.012	0.012	CcSEcCtD
Tinidazole—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.012	0.012	CcSEcCtD
Tinidazole—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Tinidazole—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0118	CcSEcCtD
Tinidazole—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0117	CcSEcCtD
Tinidazole—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Tinidazole—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Tinidazole—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Tinidazole—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.011	0.011	CcSEcCtD
Tinidazole—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Tinidazole—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0106	CcSEcCtD
Tinidazole—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Tinidazole—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Tinidazole—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00981	0.00981	CcSEcCtD
Tinidazole—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00955	0.00955	CcSEcCtD
Tinidazole—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00942	0.00942	CcSEcCtD
Tinidazole—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00911	0.00911	CcSEcCtD
Tinidazole—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00881	0.00881	CcSEcCtD
Tinidazole—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00847	0.00847	CcSEcCtD
Tinidazole—Rash—Hydrochlorothiazide—nephrolithiasis	0.0084	0.0084	CcSEcCtD
Tinidazole—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00839	0.00839	CcSEcCtD
Tinidazole—Headache—Hydrochlorothiazide—nephrolithiasis	0.00834	0.00834	CcSEcCtD
Tinidazole—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00791	0.00791	CcSEcCtD
